112 related articles for article (PubMed ID: 1338473)
1. Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock.
Symington PA; Ma XL; Lefer AM
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):789-97. PubMed ID: 1338473
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats.
Harbrecht BG; Wu B; Watkins SC; Billiar TR; Peitzman AB
Shock; 1997 Dec; 8(6):415-21. PubMed ID: 9421854
[TBL] [Abstract][Full Text] [Related]
3. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
Ng SS; Pang CC
Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
[TBL] [Abstract][Full Text] [Related]
4. Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock.
Christopher TA; Ma XL; Lefer AM
Shock; 1994 Jan; 1(1):19-24. PubMed ID: 7743323
[TBL] [Abstract][Full Text] [Related]
5. S-Nitroso-N-acetylpenicillamine (SNAP) during hemorrhagic shock improves mortality as a result of recovery from vascular hyporeactivity.
Sato S; Suzuki A; Nakajima Y; Iwamoto T; Bito H; Miyabe M
Anesth Analg; 2000 Feb; 90(2):362-8. PubMed ID: 10648322
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock.
Skurk C; Nuss C; Lefer AM
Shock; 1995 Jan; 3(1):13-20. PubMed ID: 7531603
[TBL] [Abstract][Full Text] [Related]
8. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
Shaffer JE; Han BJ; Chern WH; Lee FW
J Pharmacol Exp Ther; 1992 Jan; 260(1):286-93. PubMed ID: 1731043
[TBL] [Abstract][Full Text] [Related]
9. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug.
Megson IL; Greig IR; Gray GA; Webb DJ; Butler AR
Br J Pharmacol; 1997 Dec; 122(8):1617-24. PubMed ID: 9422806
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases.
Fricker SP; Slade E; Powell NA; Vaughan OJ; Henderson GR; Murrer BA; Megson IL; Bisland SK; Flitney FW
Br J Pharmacol; 1997 Dec; 122(7):1441-9. PubMed ID: 9421293
[TBL] [Abstract][Full Text] [Related]
11. Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Jul; 124(6):1219-26. PubMed ID: 9720794
[TBL] [Abstract][Full Text] [Related]
12. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
Bitterman H; Smith BA; Lefer AM
Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
[TBL] [Abstract][Full Text] [Related]
13. Administration of a nitric oxide donor does not affect hypotension induced by 35-GHz microwave heating.
Ryan KL; Lovelace JD; Frei MR; Jauchem JR
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):455-64. PubMed ID: 9413828
[TBL] [Abstract][Full Text] [Related]
14. Decreased hypotensive responsiveness to nitric oxide donor S-nitroso N-acetyl-DL-penicillamine (SNAP) in spontaneously hypertensive (SHR) rats.
Styś T; Styś A; Paczwa P; Szczepańska-Sadowska E; Lipkowski AW
J Physiol Pharmacol; 1998 Mar; 49(1):37-49. PubMed ID: 9594409
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
[TBL] [Abstract][Full Text] [Related]
16. Peroxynitrite leads to arteriolar smooth muscle cell membrane hyperpolarization and low vasoreactivity in severe shock.
Zhao KS; Liu J; Yang GY; Jin C; Huang Q; Huang X
Clin Hemorheol Microcirc; 2000; 23(2-4):259-67. PubMed ID: 11321449
[TBL] [Abstract][Full Text] [Related]
17. HSPTX protects against hemorrhagic shock resuscitation-induced tissue injury: an attractive alternative to Ringer's lactate.
Coimbra R; Porcides R; Loomis W; Melbostad H; Lall R; Deree J; Wolf P; Hoyt DB
J Trauma; 2006 Jan; 60(1):41-51. PubMed ID: 16456435
[TBL] [Abstract][Full Text] [Related]
18. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
[TBL] [Abstract][Full Text] [Related]
19. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
Bitterman H; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of combined treatment with oxygen and hypertonic saline in hemorrhagic shock.
Brod VI; Krausz MM; Hirsh M; Adir Y; Bitterman H
Crit Care Med; 2006 Nov; 34(11):2784-91. PubMed ID: 16971851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
